Genetic modifiers of Hb E/[beta].sup.0 .sup.thalassemia identified by a two-stage genome-wide association study

First, we estimated and compared the allele frequencies of approximately 110,000 gene-based single nucleotide polymorphisms (SNPs) in pooled DNAs from different severity groups. The 756 SNPs that showed reproducible allelic differences at P [less than] 0.02 by pooling were selected for individual ge...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC medical genetics 2010-03, Vol.11, p.51
Hauptverfasser: Sherva, Richard, Sripichai, Orapan, Abel, Kenneth, Ma, Qianli, Whitacre, Johanna, Angkachatchai, Vach, Makarasara, Wattanan, Winichagoon, Pranee, Svasti, Saovaros, Fucharoen, Suthat, Braun, Andreas, Farrer, Lindsay A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:First, we estimated and compared the allele frequencies of approximately 110,000 gene-based single nucleotide polymorphisms (SNPs) in pooled DNAs from different severity groups. The 756 SNPs that showed reproducible allelic differences at P [less than] 0.02 by pooling were selected for individual genotyping. After adjustment for age, gender and geographic region, logistic regression models showed 50 SNPs significantly associated with disease severity (P [less than] 0.05) after Bonferroni adjustment for multiple testing. Forty-one SNPs in a large LD block within the [beta]-globin gene cluster had major alleles associated with severe disease. The most significant was bthal_bg200 (odds ratio (OR) = 5.56, P = 2.6 x 10.sup.-13.sup.). Seven SNPs in two distinct LD blocks within a region centromeric to the [beta]-globin gene cluster that contains many olfactory receptor genes were also associated with disease severity; rs3886223 had the strongest association (OR = 3.03, P = 3.7 x 10.sup.-11.sup.). Several previously unreported SNPs were also significantly associated with disease severity. These results suggest that there may be an additional regulatory region centromeric to the [beta]-globin gene cluster that affects disease severity by modulating fetal hemoglobin expression.
ISSN:1471-2350
1471-2350
DOI:10.1186/1471-2350-11-51